• Home
  • Contact Us
  • Try it!
  • Blog
  • Vizit Graphs

Follow us

Recent Posts

  • Business Development Agent in Japan February 12, 2020
  • High Throughput Layout and Copy Paste July 5, 2019
  • Biovista in World’s Top 20 AI Drug Development Companies March 22, 2019
  • Biovista signs EU-IMI2 research agreement to advance neurotoxicity de-risking in preclinical drug discovery March 15, 2019
  • The increasing importance of predicting AEs & the role of Augmented Intelligence September 10, 2018

Biovista Vizit

Biovista Vizit

  • Try it!
  • Blog
  • Vizit Graphs

NIVOLUMAB

Immune checkpoint blockade in cancer immunotherapy

August 28, 2018Cancer, Cancer Immunotherapy, Vizit Graphs
Immune checkpoint blockade in cancer immunotherapy

Explore immune checkpoint blockade (PD-1, CTLA-4) in cancer immunotherapy with Biovista Vizit. Explore the live graph.

Vizit Graphs Tag Cloud

IFNG CASP3 SOD1 APOPTOTIC PROCESS NEURODEGENERATIVE DISORDERS CELL DIVISION TH17 CELLS STAPHYLOCOCCUS AUREUS CANCER PSEUDOMONAS AERUGINOSA TNF CANDIDA ALBICANS PARKINSON DISEASE TP53 CLOSTRIDIUM DIFFICILE AUTOPHAGY FOXP3 ESCHERICHIA COLI CD4 DIABETES MELLITUS REMICADE IL23A HELICOBACTER PYLORI ANGIOGENESIS IL6 ALZHEIMER'S DISEASE AGING ERBB-2 IMMUNE RESPONSE CELL PROLIFERATION IL17A LISTERIA MONOCYTOGENES 1-METHYL-4-PHENYL-1-2-3-6-TETRAHYDROPYRIDINE CELL DIFFERENTIATION RECEPTOR BREAST CANCER RHEUMATOID ARTHRITIS STREPTOCOCCUS PNEUMONIAE CELL DEATH INFLAMMATION INSULIN CTLA4 DOXORUBICIN METFORMIN PORPHYROMONAS GINGIVALIS

© 2020 Biovista Vizit All Rights Reserved.